Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis

Prognostic Factors for Myositis-Associated Interstitial Lung Disease

(2014) Tomoyuki Fujisawa et al.   PLoS One

Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis

(2013) Zhiyong Chen et al.   ARTHRITIS CARE & RESEARCH

Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum

(2013) John C. Hall et al.   ARTHRITIS CARE & RESEARCH

Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

(2011) Yasuhito Hamaguchi et al.   ARCHIVES OF DERMATOLOGY

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

(2011) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Interstitial Lung Disease in Classic and Skin-Predominant Dermatomyositis

(2010) Pamela A. Morganroth et al.   ARCHIVES OF DERMATOLOGY

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

(2010) T. Gono et al.   RHEUMATOLOGY

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM